West Pharmaceutical Services | WST - Operating Expenses

Stock Price
248.06
Daily Change
2.20 0.89%
Monthly
1.85%
Yearly
9.74%
Q1 Forecast
238.44

West Pharmaceutical Services reported $642.5M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Align Technology USD 822.85M 11.8M Dec/2025
Avanos Medical USD 156.13M 2.7M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Cerus USD 34.78M 2.98M Dec/2024
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Cooper Companies USD 811.3M 113.5M Dec/2025
Dentsply International USD 423M 1.06B Dec/2025
Haemonetics USD 134.99M 1.26M Dec/2025
ICU Medical USD 514.62M 4.48M Dec/2025
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
J&J USD 18.97B 2.38B Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Merit Medical Systems USD 339.74M 1.8M Dec/2025
Neogen USD 230.07M 4.79M Sep/2025
OraSure Technologies USD 23.07M 4.36M Sep/2024
Quidel USD 760.9M 1.28B Dec/2025
Repligen USD 177.94M 1.82M Dec/2025
Rockwell Medical USD 30.41M 1.11M Jun/2025
Solventum Corp USD 1.89B 3.09B Dec/2025
STAAR Surgical USD 68.74M 1.55M Dec/2025
Terumo JPY 252.74B 22.88B Dec/2025
Utah Medical Products USD 6.25M 80K Sep/2024
West Pharmaceutical Services USD 642.5M 2.41B Dec/2025